Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management

被引:30
作者
Corso, G.
Roviello, F.
Paredes, J.
Pedrazzani, C.
Novais, M.
Correia, J.
Marrelli, D.
Cirnes, L.
Seruca, R.
Oliveira, C.
Suriano, G.
机构
[1] Univ Porto, Inst Mol Pathol & Immunol, P-4200465 Oporto, Portugal
[2] Univ Siena, Div Surg Oncol, Dept Human Pathol & Oncol, I-53100 Siena, Italy
[3] Univ Porto, Fac Med, P-4100 Oporto, Portugal
来源
EJSO | 2007年 / 33卷 / 09期
关键词
HDGC; E-cadherin germline missense mutation; fit vitro analysis; second inactivating hit; clinical management;
D O I
10.1016/j.ejso.2007.03.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: Hereditary diffuse gastric cancer (HDGC) is a cancer susceptibility syndrome caused by E-cadherin germline mutations. One-third of these mutations are of the missense type, representing a burden in genetic counselling. A new germline missense mutation (P373L) was recently identified in a HDGC Italian family. The present work aimed at addressing the disease-causative nature of the P373L mutant. Methods: Assessment of the P373L mutation effect was based on cell aggregation and invasion assays. LOH analysis at the E-cadherin locus, search for somatic E-cadherin mutations and for promoter hypermethylation were performed to identify the mechanism of inactivation of the E-cadherin wild-type allele in the tumour. Results: In vitro the P373L germline mutation impaired the E-cadherin functions. E-cadherin promoter hypermethylation was observed in the tumour of the P373L mutation carrier. Conclusion: We conclude that the combination of clinical, in vitro and molecular genetic data is helpful for establishing an accurate analysis of HDGC-associated CDH1 germline missense mutations and subsequently for appropriate clinical management of asymptomatic mutation carriers. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1061 / 1067
页数:7
相关论文
共 27 条
[1]  
Berx G, 1998, HUM MUTAT, V12, P226, DOI 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO
[2]  
2-D
[3]   CADHERIN EXPRESSION IN CARCINOMAS - ROLE IN THE FORMATION OF CELL-JUNCTIONS AND THE PREVENTION OF INVASIVENESS [J].
BIRCHMEIER, W ;
BEHRENS, J .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1994, 1198 (01) :11-26
[4]   Hereditary diffuse gastric cancer: Diagnosis and management [J].
Blair, V ;
Martin, I ;
Shaw, D ;
Winship, I ;
Kerr, D ;
Arnold, J ;
Harawira, P ;
McLeod, M ;
Parry, S ;
Charlton, A ;
Findlay, M ;
Cox, B ;
Humar, B ;
More, H ;
Guilford, P .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (03) :262-275
[5]   Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria [J].
Brooks-Wilson, AR ;
Kaurah, P ;
Suriano, G ;
Leach, S ;
Senz, J ;
Grehan, N ;
Butterfield, YSN ;
Jeyes, J ;
Schinas, J ;
Bacani, J ;
Kelsey, M ;
Ferreira, P ;
MacGillivray, B ;
Macleod, P ;
Micek, M ;
Ford, J ;
Foulkes, W ;
Australie, K ;
Greenberg, C ;
LaPointe, M ;
Gilpin, C ;
Nikkel, S ;
Gilchrist, D ;
Hughes, R ;
Jackson, CE ;
Monaghan, KG ;
Oliveira, MJ ;
Seruca, R ;
Gallinger, S ;
Caldas, C ;
Huntsman, D .
JOURNAL OF MEDICAL GENETICS, 2004, 41 (07) :508-517
[6]   Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening [J].
Carneiro, F ;
Huntsman, DG ;
Smyrk, TC ;
Owen, DA ;
Seruca, R ;
Pharoah, P ;
Caldas, C ;
Sobrinho-Simoes, M .
JOURNAL OF PATHOLOGY, 2004, 203 (02) :681-687
[7]   Deregulation of E-cadherin-catenin complex in precancerous lesions of gastric adenocarcinoma [J].
Chan, AOO ;
Wong, BCY ;
Lan, HY ;
Loke, SL ;
Chan, WK ;
Hui, WM ;
Yuen, YH ;
Ng, I ;
Hou, L ;
Wong, WM ;
Yuen, MF ;
Luk, JMC ;
Lam, SK .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (05) :534-539
[8]   The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion [J].
Comijn, J ;
Berx, G ;
Vermassen, P ;
Verschueren, K ;
van Grunsven, L ;
Bruyneel, E ;
Mareel, M ;
Huylebroeck, D ;
van Roy, F .
MOLECULAR CELL, 2001, 7 (06) :1267-1278
[9]   Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer [J].
Grady, WM ;
Willis, J ;
Guilford, PJ ;
Dunbier, AK ;
Toro, TT ;
Lynch, H ;
Wiesner, G ;
Ferguson, K ;
Eng, C ;
Park, JG ;
Kim, SJ ;
Markowitz, S .
NATURE GENETICS, 2000, 26 (01) :16-17
[10]   E-cadherin germline mutations in familial gastric cancer [J].
Guilford, P ;
Hopkins, J ;
Harraway, J ;
McLeod, M ;
McLeod, N ;
Harawira, P ;
Taite, H ;
Scoular, R ;
Miller, A ;
Reeve, AE .
NATURE, 1998, 392 (6674) :402-405